You are here: Industry Insights > aspirin

News List

Aspirin May No Longer Have Effect in Primary CVD Prevention drugs
December 24, 2019
Aspirin may not be effective for primary prevention of cardiovascular disease and cancer mortality, according to research published online in Family Practice.
Low-Dose Aspirin May Cut Dementia Risk in Women With Diabetes drugs
December 19, 2019
Long-term use of low-dose aspirin may reduce the risk for dementia in women with type 2 diabetes, according to a study published online in Diabetes Care.
ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients drugs
September 24, 2019
Nonsteroidal anti-inflammatory drugs (NSAIDs) are correlated with better overall survival in patients with head and neck squamous cell carcinoma (HNSCC) ...
Can Aspirin Help Tackle Some Cancers? drugs
September 24, 2019
Low-dose aspirin may improve survival odds for patients battling head/neck and lung cancer, two new studies suggest.
Could Daily Low-Dose Aspirin Still Help Some People? drugs
September 17, 2019
Debate over the benefits and drawbacks of daily low-dose aspirin has flared in recent years, with guidelines now generally urging against the regimen to prevent a first heart attack or stroke in healthy people.
Benefit, Harm Seen for Ticagrelor Plus Aspirin in Stable CAD With T2DM drugs
September 04, 2019
Ticagrelor plus aspirin compared with placebo plus aspirin is associated with a lower incidence of ischemic cardiovascular events but a higher incidence of major bleeding among patients with ...
Explanation found for high mortality in breast cancer patients taking aspirin pharmaceutical-technology
August 13, 2019
Researchers from the University of North Carolina (UNC) at Chapel Hill, US, have identified that wide variations in the mortality risk of breast cancer patients taking aspirin could be related to the DNA methylation profile in their tumours or peripheral
Aspirin May Improve Liver Function After Embolization of HCC drugs
August 13, 2019
Aspirin therapy can improve liver function and survival in patients who have received chemoembolization or transarterial embolization for hepatocellular carcinoma...
Almost One in Four Adults ≥ 40 Takes Aspirin for CVD Prevention drugs
July 23, 2019
Nearly 30 million U.S. adults aged 40 years or older use aspirin to prevent cardiovascular disease (CVD), including 6.6 million without a physician's recommendation...
Providers, Peers Influence Aspirin Use Among African-Americans drugs
June 03, 2019
Providers, Peers Influence Aspirin Use Among African-Americans.

Previous page 1 2 3 4 5 6 Next page